Table 3 Prevalence of the comorbidities investigated (n = 125)
Comorbidity | Age < 50 years, n = 65 | Age ≥ 50 years, n = 60 | Odds ratio (95% CI) | P value |
|---|---|---|---|---|
Systemic arterial hypertension | 2 (3.1%) | 20 (33%) | 15.1 (3.3–68.1) | < 0.001 |
Osteoarthritis | 3 (4.6%) | 20 (33.3%) | 9.9 (2.7–35.5) | < 0.001 |
Hyperlipidemia | 40 (61.5%) | 49 (81.7%) | 2.9 (1.2–6.6) | 0.009 |
Diabetes mellitus | 1 (1.5%) | 11 (18.3%) | 13.8 (1.7–110.9) | 0.002 |
Acid peptic disease | 4 (6.2%) | 12 (20%) | 3.6 (1.15–12.1) | 0.032 |
Obesity, BMI > 30 kg/m2 | 3 (4.6%) | 11 (18.3%) | 4.47 (1.18–16.9) | 0.023 |
HBV coinfection | 6 (9.2%) | 11 (18.3%) | 2.12 (0.73–6.16) | 0.158 |
Heart failure and/or coronary heart disease | 1 (1.5%) | 1 (1.7%) | 1.05 (0.64–17.16) | 1.0 |
Chronic kidney disease | 3 (4.6%) | 4 (6.7%) | 1.42 (0.30–6.65) | 0.713 |
Current malignant tumors | 2 (2.7%) | 4 (6.7%) | 2.25 (0.39–12.75) | 0.348 |
Current sexually transmitted disease | 21 (32.3%) | 11 (18.3%) | 0.47 (0.20–1.08) | 0.074 |
Liver disease | 0 (0%) | 2 (3.3%) | 0.138 | |
Chronic obstructive pulmonary disease | 0 (0%) | 1 (1.7%) | 0.296 |